Πέμπτη 30 Μαρτίου 2017

Immunotherapy: DLBCL remissions driven by CARs.

Related Articles

Immunotherapy: DLBCL remissions driven by CARs.

Nat Rev Clin Oncol. 2017 Mar 29;:

Authors: Killock D

PMID: 28352132 [PubMed - as supplied by publisher]



http://ift.tt/2njqDQl

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου